• to reduced the potential risk of serious cardiovascular (heart and blood vessel) difficulties in adults with form 2 diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched options for an experimental weight loss capsule in May possibly but is still hoping for just a slice of the industry with MariTide, a month-to-month inje